Templum to Offer Premier Private Market Investment Opportunities in Perplexity AI, OpenAI, and Colossal Biosciences to SoFi Members
Rhea-AI Summary
Templum and SoFi (NASDAQ: SOFI) launched a limited-time private market window (March 5–March 30, 2026) giving accredited investors access to Perplexity AI, OpenAI, and Colossal Biosciences via the Cosmos Fund.
The offer allows verified accredited investors to allocate to one, two, or all three assets; Cosmos Fund will continue limited, sector-focused private placements throughout 2026.
Positive
- Limited-time access to three private market leaders (Mar 5–Mar 30, 2026)
- Perplexity AI reported ~22 million MAUs
- Cosmos Fund expanding to Robotics, FinTech, Defense Tech, Infrastructure in 2026
Negative
- Offer restricted to accredited investors, excluding most retail investors
- Investment window lasts 25 days, creating time pressure for decisions
News Market Reaction – SOFI
On the day this news was published, SOFI gained 2.94%, reflecting a moderate positive market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $701M to the company's valuation, bringing the market cap to $24.55B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SOFI was up 0.48% pre-news while key credit/fintech peers like PYPL (+1.52%), COF (+0.68%), ALLY (+0.65%), and SYF (+0.17%) saw modest gains and OMF (-0.67%) lagged. No peers appeared in momentum scans, pointing to a stock-specific AI/private-markets narrative rather than a broad sector rotation.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 26 | AI conference appearance | Positive | +4.3% | Participation in UBS Global Technology & AI Conference with CFO fireside chat. |
| Sep 03 | AI ETF launch | Positive | -1.7% | Launch of SoFi Agentic AI ETF focused on agentic AI companies and index. |
AI-tag news has produced mixed reactions: one conference appearance drew a solid gain, while the AI ETF launch saw a modest decline, yielding an average move of 1.32%.
Over the past year, SOFI’s AI-tagged updates have focused on building credibility and distribution in emerging AI themes. On September 3, 2025, it launched the Agentic AI ETF (AGIQ) tracking an AI-focused index. On November 26, 2025, management highlighted AI strategy at the UBS Global Technology & AI Conference, which corresponded with a 4.32% gain. Today’s Cosmos Fund access to OpenAI, Perplexity AI, and Colossal Biosciences extends that AI positioning into private-market opportunities for members.
Historical Comparison
In the past year, SOFI issued 2 AI-related updates with an average move of 1.32%. Today’s Cosmos Fund access to leading AI names fits this ongoing AI-focused product strategy.
SOFI’s AI narrative has progressed from launching an AI-focused ETF and presenting at an AI conference to now providing members curated private-market exposure to AI and biotech leaders via the Cosmos Fund.
Regulatory & Risk Context
SOFI has an effective S-3ASR shelf registration dated 2025-07-29, expiring 2028-07-29, with at least one usage event via a 424B3 filing on 2025-12-05. While no capacity amounts are provided, the active shelf gives the company flexibility to issue securities via prospectus supplements as needed.
Market Pulse Summary
This announcement highlights SOFI’s push to differentiate its platform by offering accredited members access to private-market leaders like OpenAI, Perplexity AI, and Colossal Biosciences through a limited window from March 5–30, 2026. It builds on prior AI-related efforts, including an AI ETF and participation in an AI conference. Investors may watch uptake of the Cosmos Fund opportunities and how effectively SOFI integrates AI and private-market access into its broader financial services ecosystem.
Key Terms
accredited investors regulatory
de-extinction medical
monthly active users technical
AI-generated analysis. Not financial advice.
Limited-time offering provides investors access to highly sought-after private market leaders
The three offerings will be available from March 5 through March 30, 2026, and represent the latest opportunities from the Cosmos Fund, which is designed to provide differentiated access to category-defining private companies for qualified investors.
OpenAI, Perplexity AI, and Colossal Biosciences – pioneers in their respective digital and biological markets – are redefining what's possible today across their sectors.
- Colossal Biosciences is pursuing a proprietary biotech platform with applications spanning de-extinction, species preservation, livestock optimization, climate science, and human therapeutics. The company's latest report states that it has achieved decacorn status, with backing from investors including TWG Global and other leading venture capital firms.
- OpenAI is striving to establish the operating system and infrastructure underpinning much of the next generation of AI innovation. Its enormous scale provides substantial data, distribution, and ecosystem advantages.
- Perplexity AI is focused on transforming how we digitally search with an AI search engine that uses referenceable data and facts to provide answers. The company's recent highlights include the launch of its Comet browser and the milestone of reaching approximately 22 million monthly active users (MAUs).
Accredited investors, once verified, have the option to allocate capital to any individual asset or across all three offerings. For additional details or to discuss participation, investors may visit www.sofi.com/invest/private-markets or contact Templum's investor support directly.
Looking forward, the Cosmos Fund will feature select investments from high-growth sectors, including Robotics, FinTech, Defense Technology, and Infrastructure, offered as limited, time-sensitive opportunities alongside top-tier investment products from industry-leading asset managers from Templum Markets throughout 2026.
About Templum
Templum is moving private markets investing forward by unifying the entire ecosystem. As a solution partner, Templum provides full investment lifecycle technologies, workflow solutions, and broker-dealer support configurable via white label, hybrid, or API deployments. The Company's offerings are purpose-built to enable private market strategies for wealthtech providers, RIAs, institutional brokers, banks, fintechs, online brokers, and asset managers. Templum is modernizing the technology backbone and opening access to a broader range of investment opportunities for a growing investor base. The Company's vision is to expand capital markets, making a giant step forward from the outmoded technology hindering investments today. Learn more at https://templuminc.com.
All securities offered by Templum Markets LLC, a wholly owned broker-dealer and Alternative Trading System (ATS) subsidiary of Templum, Inc. For more information, please visit https://templuminc.com. Templum does not have an affiliation with, formal relationship with, or endorsement from OpenAI, Perplexity AI, and Colossal Biosciences. None of the statements on this document should be attributed to OpenAI, Perplexity AI, Colossal Biosciences or its affiliates.
INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE |
SoFi Invest is a trade name used by SoFi Wealth LLC and SoFi Securities LLC offering investment products and services. Robo investing and advisory services are provided by SoFi Wealth LLC, an SEC-registered investment adviser. Brokerage and self-directed investing products offered through SoFi Securities LLC, Member FINRA/SIPC.
For disclosures on SoFi Invest platforms visit SoFi.com/legal. For a full listing of the fees associated with SoFi Invest please view our fee schedule
View original content to download multimedia:https://www.prnewswire.com/news-releases/templum-to-offer-premier-private-market-investment-opportunities-in-perplexity-ai-openai-and-colossal-biosciences-to-sofi-members-302704743.html
SOURCE Templum Inc.
FAQ
What private companies can SoFi (SOFI) members access in the March 2026 offering?
Who is eligible to participate in the SOFI private market window from March 5–30, 2026?
How long is the Cosmos Fund private offering available to SOFI members in March 2026?
Can SOFI (SOFI) investors split allocations across multiple private assets in this offering?
What traction does Perplexity AI show in the Cosmos Fund offering promoted to SOFI members?
Will the Cosmos Fund offer other sectors to SOFI members after March 2026?